Nat Commun
December 2021
For the first time, lasing at NV centers in an optically pumped diamond sample is achieved. A nanosecond train of 150-ps 532-nm laser pulses was used to pump the sample. The lasing pulses have central wavelength at 720 nm with a spectrum width of 20 nm, 1-ns duration and total energy around 10 nJ.
View Article and Find Full Text PDFJ Psychiatr Res
November 2021
Generalized anxiety disorder (GAD) is associated with an imbalance in the functioning of the stimulating neurotransmitter systems in human's brain. We studied the safety and therapeutic efficacy of aviandr, the new noradrenergic and specific serotonergic antidepressant, for GAD patients in the phase II, double-blind, placebo-controlled, randomized, multicenter, pilot trial at 17 clinical sites of the Russian Federation. 129 eligible patients were 18 years and older and met the criteria for GAD diagnosis.
View Article and Find Full Text PDFIntroduction: The pathophysiological mechanisms of acute schizophrenia are largely unknown, but it is widely accepted that dopamine D2 receptors (DRD2s) are involved in psychosis treatments for schizophrenic patients. We suggest that genetic variation in these receptors may play a role in patients' responses to commonly used antipsychotics, particularly D2-blockers.
Methods: This study included adult patients with ICD-10 diagnoses of schizophrenia and current acute psychosis who were treated with antipsychotics.
Spectral imaging in the near infrared is a promising method for mineralogy analysis, in particular well-suited for airless celestial objects or those with faint atmospheres. Additional information about structure and composition of minerals can be obtained using spectral polarimetry with high spatial resolution. We report design and performance of laboratory prototype for a compact near infrared acousto-optic imaging spectro-polarimeter, which may be implemented for remote or close-up analysis of planetary surfaces.
View Article and Find Full Text PDFBackground: Treating patients who experience residual psychotic symptoms during remission of schizophrenia remains one of the most challenging problems. The mechanisms underlying these symptoms differ from those of acute hallucinations and delusions. 5-HT6 receptor antagonists have been considered promising agents in treatment of residual psychotic symptoms and cognitive dysfunction.
View Article and Find Full Text PDFCNS Spectr
August 2014
Unlabelled: The serotoninergic system as a target for add-on treatment seems to be a promising approach in patients with schizophrenia.
Objective: To clarify if selective 5HT-6 antagonist AVN-211 (CD-008-0173) adds clinical and cognitive effects to stable antipsychotic treatment.
Methods: A randomized, double-blind, placebo-controlled, add-on, 4r-week trial in 47 schizophrenia patients (21 patients receiving study drug and 26 receiving placebo) who were stabilized on antipsychotic medication was performed.